Tags : Distribution

AstraZeneca Signs a Worldwide Development and Distribution Agreement with Oxford

Shots: The collaboration will bring Oxford’s recombinant adenovirus vaccine, ChAdOx1 nCoV-19 to the patients and will enable AstraZeneca to be responsible for the development and WW manufacturing and distribution of the vaccine The alliance will combine Oxford’s expertise in vaccinology and AstraZeneca’s global development, manufacturing and distribution capabilities to combat the pandemic ChAdOx1 is based […]Read More

Mundipharma Signs an Exclusive Commercialization and Distribution Agreement with Biosolution

Shots: Mundipharma to get exclusive rights to market and distribute Biosolution’s CartiLife in South Korea. In May 2016, the companies signed commercialization agreement for allogeneic keratinocyte cell therapy product, KeraHeal-Allo and is the second agreement signed presently The focus of the agreement is to include Biosolution’s CartiLife in the Mundipharma’s portfolio of orthopedic care CartiLife […]Read More

Helsinn Enters into an Exclusive Distribution and License Agreement with

Shots: Blanver to register, promote, distribute & commercialize Pracinostat in Brazil while Varifarma to get rights in Argentina, Bolivia, Chile, Colombia, Ecuador, Paraguay, Peru, and Uruguay. Helsinn to retain rights all international developments including clinical activities & supply of Pracinostat In 2016, MEI Pharma granted global rights of Pracinostat to Helsinn and a right to […]Read More

MVP and Daiichi Signs Exclusive Distribution and License Agreement for

Shots: Medical Developments International (MVP) to receive up to $32.5M (AUD $45.8M) as total deal value plus $15M upfront and additional sales-based milestones payments MVP will fund the regulatory process of Penthrox in China and both companies will jointly collaborate with Japan’s service provider, EPS International Holdings for its approval. MVP will hold the drug […]Read More